RAY1225
Evaluation of RAY1225 in Adult Participants Who Have Obesity or Are Overweight
Guangdong Raynovent Biotech Co · Phase 3 · Recruiting · Enrollment 640
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| RAY1225 High Dose | n/r | n/r | n/r | n/r | n/r |
| RAY1225 Medium Dose | n/r | n/r | n/r | n/r | n/r |
| RAY1225 Low Dose | n/r | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.